The current valuation score of Can Fite Biopharma Ltd is 7.81, ranking 114 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -0.00, which is -165746.15% below the recent high of 4.31 and -23386061.54% above the recent low of -608.04.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.